Ursula von der Leyen, President of the European Commission, faced a stormy session in the European Parliament yesterday as she mounted a firm defence of her record amid mounting criticism over COVID-19 vaccine procurement and accusations of opaque decision-making.
The censure motion, spearheaded by a coalition of far-right Members of the European Parliament (MEPs), accused the Commission chief of secrecy, overreach, and mishandling of critical contracts during the pandemic.
Despite the drama on the chamber floor, the motion is expected to fall well short of the two-thirds majority required to pass, thanks in part to the backing of centrist and mainstream parties. Yet the episode has laid bare the simmering discontent with von der Leyen’s leadership style and rekindled concerns about the lack of transparency at the heart of Brussels’ executive power.
Central to the controversy is von der Leyen’s role in negotiating a massive COVID-19 vaccine deal with pharmaceutical giant Pfizer in 2021. Critics have long pointed to her personal involvement, specifically, a series of private text messages exchanged with Pfizer CEO Albert Bourla—as evidence of an informal, unaccountable approach to EU governance. The texts, never formally released despite repeated requests from the European Ombudsman and journalists, have become symbolic of the Commission’s wider reluctance to subject itself to public scrutiny.
In her remarks, von der Leyen refused to be drawn on the specifics of the Pfizer communication, insisting instead that the Commission’s pandemic response “saved millions of lives” and had been conducted “in the best interests of all Europeans.” She pointed to the bloc’s eventual success in securing doses for 27 member states as proof that the Commission’s actions were justified by extraordinary circumstances.
“The decisions we took were difficult,” she said. “They were made in the fog of an unprecedented crisis. But they were taken responsibly, collectively, and with one goal: to protect Europe’s citizens.”
A Fractured Parliament
The motion was introduced by Identity and Democracy (ID), the hard-right grouping that includes Marine Le Pen’s Rassemblement National and Italy’s League, among others. The ID group accused von der Leyen of bypassing parliamentary oversight, undermining democratic accountability, and presiding over a Commission increasingly detached from member states.
French MEP Thierry Mariani said: “This is not about vaccines. It is about the rule of law. The Commission President has behaved as though she is above the institutions. That cannot stand.”
Yet opposition to von der Leyen was far from confined to the fringes. Green and Left MEPs also expressed discomfort with the Commission’s lack of transparency, while even some centrist Renew Europe figures privately voiced concern over her centralising tendencies.
Nevertheless, the numbers are not on the rebels’ side. The European People’s Party, to which von der Leyen belongs, remains the largest group in the chamber and has closed ranks in her defence. Renew Europe and the Socialists & Democrats have signalled they will oppose the censure motion, if only to preserve institutional stability amid growing geopolitical uncertainty.
Shadow of 2024 Lingers
Though von der Leyen appears likely to survive this latest challenge, the affair has sharpened the debate over her potential reappointment in 2024. Behind closed doors, several national capitals remain uneasy about her tenure particularly as questions persist over how she was first nominated in 2019, bypassing the Spitzenkandidat system that many MEPs still consider the gold standard for democratic legitimacy.
“Von der Leyen’s tenure has been marked by efficiency, but also by opacity,” said one senior EU diplomat. “She runs a tight ship, but some worry the crew doesn’t know where it’s headed.”
The Commission President has yet to formally declare her intention to seek a second term, though many in Brussels expect her to do so later this year. The censure vote, while destined to fail, could serve as a bellwether of parliamentary sentiment as the 2024 elections approach.
Institutional Questions Remain
Beyond the political theatre, the episode has renewed calls for greater transparency and oversight of the Commission’s executive functions. The European Ombudsman has repeatedly chastised the Commission for its handling of public access requests and its failure to maintain proper records of key decisions.
“Accountability must be built into crisis management,” said Ombudsman Emily O’Reilly in a recent statement. “The pandemic cannot be a permanent excuse for secrecy.”
For now, von der Leyen appears secure in her position. But the mounting scrutiny of her leadership style, along with the unresolved questions over vaccine contracts, suggests that the age of technocratic immunity in Brussels may be drawing to a close.
As one veteran MEP quipped after the vote: “She may have dodged the bullet, but she hasn’t disarmed the gun.”
